N-acetylcysteine ameliorates oxidative stress-induced decline in sex hormone-binding globulin in HepG2 cells and polycystic ovary syndrome rats
- 1Laboratory of Genetic Disease and Perinatal Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University
- 2School of Life Science and Engineering, Southwest Jiaotong University
- 3Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University
Abstract
Background: Low sex hormone-binding globulin (SHBG) levels are a significant indicator of hyperandrogenism severity in patients with polycystic ovary syndrome (PCOS) and are associated with an increased risk of reproductive and metabolic diseases. Oxidative stress suppresses the production and secretion of SHBG. However, the effect of the antioxidant N-acetylcysteine (NAC) on hepatic SHBG expression remains unknown. This study investigated the effects of NAC on SHBG expression and the underlying mechanism in HepG2 cells and a rat model of PCOS.
Methods: HepG2 cells were treated with testosterone propionate (TP), oxidized high-density lipoprotein (ox-HDL), oxidized low-density lipoprotein (ox-LDL), and NAC. Female Sprague-Dawley rats aged 28 days were randomly allocated to eight groups: control, PCOS, and control and PCOS groups treated with NAC at 100, 200, or 400 mg/kg body weight. The PCOS rat model, induced by TP and a high-fat, high-sugar diet, was treated with different doses of NAC for 8 weeks. The expression of SHBG, hepatocyte nuclear factor 4α (HNF4α), chicken ovalbumin upstream promoter-transcription factor 1 (COUP-TF1), and peroxisome proliferator-activated receptor-γ (PPAR-γ) was assessed in HepG2 cells and rat liver tissue. Metabolic, hormonal, and oxidative stress indices were analyzed in the rat model.
Results: In HepG2 cells, TP and oxidized lipoprotein treatments significantly suppressed SHBG and HNF4α expression, while NAC treatment reversed the inhibitory effects induced by ox-HDL and ox-LDL ( P < 0.05). In PCOS rats, NAC intervention increased the mRNA and protein levels of SHBG by upregulating HNF4α and downregulating COUP-TF1 and PPAR-γ expression in the liver; increased serum SHBG; reduced hepatocytic reactive oxygen species levels ( P < 0.05); and ameliorated obesity, estrous cycle abnormalities, hepatic steatosis, circulating sex hormone levels, and the lipid profile, with 200 mg/kg NAC showing the most favorable overall pattern among the three doses tested.
Conclusion: NAC treatment ameliorates oxidative stress-induced decreases in SHBG and HNF4α expression in HepG2 cells and may restore hepatocytic SHBG production by upregulating HNF4α and downregulating COUP-TF1/PPAR-γ expression in rats with PCOS.
Related
- Atractylenolide Ⅲ protects granulosa cells from oxidative injury by regulating the NOX2/NRF2 axis in polycystic ovary syndrome
- N-acetylcysteine attenuates oxidative-stress-associated apoptosis and collagen deposition after rat hindlimb ischemia-reperfusion injury
- Prevalence and Clinical Correlates of Polycystic Ovarian Syndrome in Patients with Interstitial Cystitis/ Bladder Pain Syndrome
- Health utility, work productivity, and total economic burden of polycystic ovary syndrome
- Polycystic ovary syndrome and menopausal transition: Hormonal dynamics, phenotypic evolution, and ethnic considerations
BibTeX
@article{zhang2026nacetylcysteine,
title = {{N-acetylcysteine ameliorates oxidative stress-induced decline in sex hormone-binding globulin in HepG2 cells and polycystic ovary syndrome rats}},
author = {Xinyuan Zhang and Qiuyi Wang and Suiyan Li and Wei Huang and Huai Bai and Qingqing Liu and Ping Fan},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1930645},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1930645/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - N-acetylcysteine ameliorates oxidative stress-induced decline in sex hormone-binding globulin in HepG2 cells and polycystic ovary syndrome rats
AU - Xinyuan Zhang
AU - Qiuyi Wang
AU - Suiyan Li
AU - Wei Huang
AU - Huai Bai
AU - Qingqing Liu
AU - Ping Fan
PY - 2026
DA - 2026/10/13
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1930645
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1930645/full
AB - Background: Low sex hormone-binding globulin (SHBG) levels are a significant indicator of hyperandrogenism severity in patients with polycystic ovary syndrome (PCOS) and are associated with an increased risk of reproductive and metabolic diseases. Oxidative stress suppresses the production and secretion of SHBG. However, the effect of the antioxidant N-acetylcysteine (NAC) on hepatic SHBG expression remains unknown. This study investigated the effects of NAC on SHBG expression and the underlying mechanism in HepG2 cells and a rat model of PCOS. Methods: HepG2 cells were treated with testosterone propionate (TP), oxidized high-density lipoprotein (ox-HDL), oxidized low-density lipoprotein (ox-LDL), and NAC. Female Sprague-Dawley rats aged 28 days were randomly allocated to eight groups: control, PCOS, and control and PCOS groups treated with NAC at 100, 200, or 400 mg/kg body weight. The PCOS rat model, induced by TP and a high-fat, high-sugar diet, was treated with different doses of NAC for 8 weeks. The expression of SHBG, hepatocyte nuclear factor 4α (HNF4α), chicken ovalbumin upstream promoter-transcription factor 1 (COUP-TF1), and peroxisome proliferator-activated receptor-γ (PPAR-γ) was assessed in HepG2 cells and rat liver tissue. Metabolic, hormonal, and oxidative stress indices were analyzed in the rat model. Results: In HepG2 cells, TP and oxidized lipoprotein treatments significantly suppressed SHBG and HNF4α expression, while NAC treatment reversed the inhibitory effects induced by ox-HDL and ox-LDL ( P < 0.05). In PCOS rats, NAC intervention increased the mRNA and protein levels of SHBG by upregulating HNF4α and downregulating COUP-TF1 and PPAR-γ expression in the liver; increased serum SHBG; reduced hepatocytic reactive oxygen species levels ( P < 0.05); and ameliorated obesity, estrous cycle abnormalities, hepatic steatosis, circulating sex hormone levels, and the lipid profile, with 200 mg/kg NAC showing the most favorable overall pattern among the three doses tested. Conclusion: NAC treatment ameliorates oxidative stress-induced decreases in SHBG and HNF4α expression in HepG2 cells and may restore hepatocytic SHBG production by upregulating HNF4α and downregulating COUP-TF1/PPAR-γ expression in rats with PCOS.
SN - 1663-9812
ER -